A 2026 review argued that G protein-coupled receptor 30 may connect estrogen signaling, trigeminal pain pathways, and migraine biology, but migraine-specific human trials of GPR30-targeted drugs are still missing. Research Highlights The migraine rationale is hormone-linked: women have roughly 2 to 3 times the migraine prevalence of men, and 50% to 60% of women with …
A 2026 cross-sectional study of 79 adults receiving hemodialysis found dialysis headache in 40 patients (50.6%), and a prior history of recurrent headaches was the strongest adjusted signal: OR = 4.08 (95% CI 1.42-11.75; p = 0.009). Research Highlights Dialysis headache was common: 40 of 79 hemodialysis patients met ICHD-3 criteria, putting frequency at 50.6% …
Migraine, a primary headache disorder, significantly impacts the quality of life of millions worldwide. In recent years, the focus has shifted toward developing targeted therapies, particularly monoclonal antibodies (mAbs) against the calcitonin-gene-related peptide (CGRP), to prevent chronic migraine attacks. A relatively recent comprehensive network meta-analysis (NMA) evaluated the efficacy and safety of various anti-CGRP mAbs, …